Trial Profile
Clinical Trials Insight: 700054368
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Mar 2010
Price :
$35
*
At a glance
- Drugs XP 21279 (Primary) ; Carbidopa; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors XenoPort